The chemopreventive effects of tea on human oral precancerous mucosa lesions

Proceedings of the Society for Experimental Biology and Medicine

Volumn 220, Issue 4, 1999, Pages 218-224

  Li, Ning ^a   Sun, Zheng ^b   Han, Chi ^a   Chen, Junshi ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Beijing Dental Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; POLYPHENOL DERIVATIVE;

ADULT; ANTIOXIDANT ACTIVITY; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME NOR; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DAMAGE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD COMPOSITION; HUMAN; HUMAN CELL; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; MOUTH CANCER; MUCOSA CELL; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

EID: 0033034809     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-37.x     Document Type: Conference Paper

References (38)

1. Mukhtar H, Wang ZH, Katiyar SK, Agareal R. Tea Components: Antimutagenic and anticarcinogenic effects. Prev Med 21:351-360, 1992.
2. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 85:1038-1049, 1993.
3. Wang ZY, Cheng JS, Zhou ZC. Antimutagenic activity of green tea polyphenols. Mutat Res 223:273-285, 1989.
4. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: Epidemiological and experimental studies (review). Int J Oncol 8:221-238, 1996.
5. Kohlmeier L, Weterings KGC, Steck S, Kok FJ. Tea and prevention: An evaluation of the epidemiological literature. Nutr Res 27:1-13, 1997.
6. Victora CG, Munoz N, Hong JGE. Hot beverages and esophageal cancer in southern Brazil: A case-control study. Int J Cancer 39:710-716, 1987.
7. Parkin SM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers. Int J Cancer 41:184-197, 1988.
8. Magrath I, Litvakk J. Cancer in developing countries: Opportunity and challenge. J Natl Cancer Inst 85:862-874, 1993.
9. Tanaka T. Chemoprevention of oral carcinogenesis. Oral Oncol, Eur J Cancer 31B:3-15, 1995.
10. Vecchia CL, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 33:302-312, 1997.
11. Sankaranarayanan R, Mathew B, Varghese C, Sudhakaran PR, Menon V, Jayadeep A, Nair MK, Mathews C, Mahalingam TR, Balaram P, Nair PP. Chemoprevention of oral leukoplakia with vitamin A and β-carotene: An assessment. Oral Oncol 33:231-236, 1995.
12. Kaugars GE, Silverman S, Ma Lovas JGL Jr., Thompson JS, Brandt RB. Use of antioxidant supplements in the treatment of human oral leukoplakia. Oral Surg Oral Med Oral Pathol 81:13, 1996.
13. Prasad MPR, Mukundan MA, Krishnaswamy K. Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity. Oral Oncol, Eur J Cancer 31B:155-159, 1995.
14. Liu LJ, Han C, Chen JS. Short-term screening of anticarcinogenic ingredients of tea by cell biology assays. J Hyg Res 27:53-56, 1998.
15. Qi L, Han C. The inhibitory effects of tea and tea-mixture on diethylnitrosamine-induced precancerous hepatic lesions in rats and its antioxidative mechanisms. J Hyg Res 26:382-386, 1997.
16. Stich HF, Rosin MP. Quantitating the synergistic effect of smoke and alcohol consumption with the micronucleus test on human buccal mucosa cells. Int J Cancer 31:305-308, 1983.
17. Ploton D, Menager M, Jeannesson P. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5-14, 1986.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroixdase complex (ABC) in immunoperoxidase techniques: A comparision between ABA qbd unlabelled PAP procedures. J Histochem Cytochem 29:577-580, 1981.
19. Greenwald P, Witkin KM, Malone WF. The study of markers of biological effect in cancer prevention research trials. Int J Cancer 52:189-196, 1992.
20. Boone CW, Kelloff GJ, Steele VE. The natural history of intraepithelial neoplasia: Relevance to the search for intermediate end point biomarkers. J Cell Biochem (Suppl 16G):23-26, 1992.
21. Lippman SM, Lee JS, Lotan R. Biomarkers as intermediate end points in chemoprevention trials. J Natl Inst Cancer 82:554-560, 1992.
22. Weinstein IB. The origins of human cancer: Molecular mechanisms and their implications for cancer prevention and treatment. Cancer Res 48:4135-4143, 1988.
23. Poppel GV, Kok FJ, Hermus RJJ. β-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer 66:1164-1168, 1992.
24. Reali DF, Dimarino S, Bahramandpour A, Carducci R. Micronuclei in exfoliated urothelial cells and urine mutagenicity in smokers. Mutat Res 192:145-149, 1987.
25. Garewal HS, Ramsey L, Kaugars G, Boyle J. Clinical experience with the micronucleus assay. J Cell Biochem (Suppl 17F):206-212, 1993.
26. Desai SS, Ghaisas SD, Jakhi SD, Bhide SV. Cytogenetic damage in exfoliated oral mucosal cells and circulating lymphocytes of patients suffering from precancerous oral lesions. Cancer Lett 109:9-14, 1996.
27. Stich HF, Stich W, Rosin MP, Vallejera MO. Use of the micronucleus test to monitor the effect of vitamin A, β-carotene and canthaxanthin on the buccal mucosa of betel nut/tobacco chewers. Int J Cancer 34:745-750, 1984.
28. Benner SE, Lippman SM, Wargovich MJ. Micronuclei, a biomarker for chemoprevention trials: Results of a randomized study in oral premalignancy. Int J Cancer 59:457, 1994.
29. Hagmar L, Brogger A, Hansteen IL, Heim S. Cancer risk in human predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922, 1994.
30. Dreosti IE. Cancer biomarkers in the field of tea. Cancer Lett 114:319-321, 1997.
31. Fakan S, Hernadez-Verdun D. The nucleus and the nucleolar organizer regions. Biol Cell 56:186-206, 1986.
32. Hall PA, Levinson DA, Woods AL. Proliferating cell nuclear antigen (PCNA) inmmunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 162:285-294, 1990.
33. Muzio LL, Mignogna MD, Staibano S, Vico GD. Morphometric study of nucleolar organizer regions (AgNOR) in HPV-associated precancerous lesions and microinvasive carcinoma of the oral cavity. Oral Oncol 33:247-259, 1997.
34. Storkel S, Reichert T, Reiffen KA. EGFR and PCNA expression in oral squamous cell carcinomas: A valuable tool in estimating the patient's prognosis. Oral Oncol, Eur J Cancer 298:273-277, 1993.
35. Shin DM, Ro JY, Hong WK. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:3153-3159, 1994.
36. Li N, Han C, Chen JS. The efficacy of various tea profucts on DMBA-induced oral carcinogenesis in hamsters. J Hyg Res 28:1999.
37. Pryou WA. Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis. Br J Cancer 55 (Suppl VIII): 19, 1987.
38. Ramaswamy G, Rao VR, Kumaraswamy SV, Anantha N. Serum vitamins' status in oral leukoplakias: A preliminary study. Oral Oncol, Eur J Cancer 32B:120-122, 1996.